PD1 and IPI Combo Trial Locations Now Enrolling
- This topic is empty.
-
Posts
-
This promising combo is accruing at the following: Dana Farber, Mass General, Beth Israel, Moffitt, University of VA., UPENN, University of Indiana, Lehigh Valley Health network (PA) If you need contact info for any of these trials, please email me:
cpoole@melanomainternational.org Great news Catherine! If the data turns out similar to that from MSK, I can easily see a future phase III trial with this combination versus either IPI or PD-1 alone. This could very well become a new standard of care if everything continues to look good.
Frank, how close is the University of Indiana to you?
Jeff
Jeff, Caught my name out of the corner of my eye. About a day’s drive away. I’m 8 days away plus from my two seizures now and will get the oncologist’s action summary a week from Tuesday as I continue on Keppra and Dexamethasone this week in declining amounts. My thought would be that I would be ineligible for a while for anything PD-1 until the brain met issue is resolved. It would not surprise me if a reinduction of ipi is recommended ASAP given the U. of M. protocol as I know it at this moment. Maybe hand in hand with SRS or even craniotomy, since there only seems to be one. But that was last week
Is this trial on clinicaltrials.gov? If so, what is the number. I have ocular melanoma and have had Ipi, so am wondering if I would qualify. Try this: http://clinicaltrials.gov/show/NCT01245556 Also, look at Jonathan’s recent post about a new agent that seems promising for ocular. Put Jonathan in the search.
http://clinicaltrials.gov/show/NCT01024231 This study lists:
Locations
United States, Connecticut
Yale University School Of Medicine Recruiting
New Haven, Connecticut, United States, 06520
Contact: Mario Sznol, Site 001 203-785-4796
United States, District of Columbia
Local Institution Not yet recruiting
Washington, District of Columbia, United States, 20057
Contact: Site 0005
United States, New York
Memorial Sloan Kettering Cancer Center Recruiting
New York, New York, United States, 11065
Contact: Jedd Wolchok, Site 003 646-422-4631
United States, Pennsylvania
Local Institution Not yet recruiting
Pittsburgh, Pennsylvania, United States, 15213-2584
Contact: Site 0004
- The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.